Newsroom

MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des résultats intermédiaires de l’étude de Phase 2 MATISSE évaluant IPH5201 en combinaison avec durvalumab et une chimiothérapie à base de platine dans le cancer du poumon non à petites cellules (CPNPC) opérable seront présentés lors d’une session plénière dédiée aux essais cliniques au congrès annuel de l’Association Américaine de la Recher...

KRAKÓW, Poland--(BUSINESS WIRE)--intoDNA announces that it will present two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Soley Therapeutics Presents Preclinical Data Demonstrating Selective Anti-Tumor Activity of STX-6398, a First-in-Class CKAP2 Modulator, at AACR 2026...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC). NG-350A combined with chemoradiotherapy (CRT) demonstrated a composite response rate of 50 percent across the first 10 patients who completed the 12-week...

SAN DIEGO--(BUSINESS WIRE)--Onchilles at AACR26: New Preclinical Data from the Systemically Delivered NEU-002 Program Supports Advancement Toward Development Candidate Selection...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum's New Preclinical Data at AACR 2026 on ORM-1153 Highlights Broad Activity in AML and the Potential for Improved Efficacy and Tolerability...

CUPERTINO, Calif.--(BUSINESS WIRE)--Most AI startups pitch a better model. Creao AI is pitching a better loop. The startup just closed a $10 million round led by Prosperity7 Ventures — the $3 billion diversified venturing fund of Aramco Ventures — bringing total funding to $25 million across three rounds in under a year. The bet: that the AI industry's real bottleneck isn't intelligence. It's the gap between a chatbot answering a question and an agent actually running your work while you sleep....

DALLAS--(BUSINESS WIRE)--SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution, today announced the presentation of new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating an integrated, high-throughput assay capable of measuring clonal tumor cell growth across thousands of individual microenvironments while preserving the full distribution of proliferative behaviors. The data...

BURLINGAME, Calif.--(BUSINESS WIRE)--NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, today announced that two poster presentations highlighting its ADC pipeline will be delivered at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026 taking place April 17-22, 2026, in San Diego, California. The AACR 2026 presentations will showcase NEOK’s emerging pipelin...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that interim results from the MATISSE Phase 2 study evaluating IPH5201 in combination with durvalumab and platinum-based chemotherapy in resectable non-small cell lung cancer (NSCLC) will be presented in one of the Clinical Trials Plenary Sessions at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22...